Bottom line
IYH vs SCHLX: the short answer
IYH (iShares U.S. Healthcare ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 76% by weight.
IYH is cheaper at 0.37% vs 1.06% — a difference of $69 a year per $10,000 invested.
Updated Nov 19, 2026
IYH vs SCHLX side by side
| IYH | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 1.06% |
| Annual cost per $10k | $37 | $106 |
| 10-yr cost on $10k (prospectus) | $468 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +13.1% | — |
| 5-yr return (annualized) | +7.0% | — |
| 10-yr return (annualized) | +9.4% | — |
| Best quarter | +15.3% | — |
| Worst quarter | −12.7% | — |
| Net assets (fund) | $3.6B | $231.8M |
| Number of holdings | 103 | 65 |
| Portfolio turnover | 3% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of IYH's top 25 holdings also appear in SCHLX's top 25.
| Holding | IYH | SCHLX |
|---|---|---|
| Eli Lilly And Company | 15.11% | 13.85% |
| Johnson & Johnson | 10.17% | 6.19% |
| Abbvie Inc. | 7.32% | 4.90% |
| Unitedhealth Group Incorporated | 6.16% | 5.73% |
| Merck & Co., Inc. | 5.31% | 4.85% |
| Thermo Fisher Scientific Incorporated | 3.52% | 3.46% |
| Amgen Inc. | 3.42% | 2.88% |
| Abbott Laboratories | 3.02% | 2.39% |
| Gilead Sciences, Inc. | 2.66% | 2.78% |
| Pfizer Inc. | 2.35% | 1.17% |
| Bristol-myers Squibb Company | 2.20% | 1.50% |
| Intuitive Surgical, Inc. | 2.05% | 2.69% |
| Danaher Corporation | 2.03% | 2.13% |
| Vertex Pharmaceuticals Incorporated | 2.00% | 2.45% |
| Stryker Corporation | 1.86% | 2.61% |
Source: SEC Form N-PORT
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between IYH and SCHLX?
IYH (iShares U.S. Healthcare ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 76% by weight. IYH is cheaper at 0.37% vs 1.06% — a difference of $69 a year per $10,000 invested.
Which is cheaper, IYH or SCHLX?
IYH has the lower expense ratio (0.37%).
Should I own both IYH and SCHLX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.